Open AccessThe efficacy of omalizumab treatment in patients with nonatopic severe asthma
Author(s) -
Emel Atayık,
Gökhan Aytekіn
Publication year - 2022
Publication title -
allergologia et immunopathologia
Language(s) - English
Resource type - Journals
eISSN - 1578-1267
pISSN - 0301-0546
DOI - 10.15586/aei.v50i5.594
Subject(s) - medicine , omalizumab , asthma , immunoglobulin e , allergy , eosinophil , sinusitis , pediatrics , immunology , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom